Article in Microbiology resource announcements, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
4 authors.
Allison M WeisDepartment of Pathology, Division of Microbiology and Immunology, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0001-9991-1661
O'Connor J MatthewsSchool of Biological Sciences, University of Utah, Salt Lake City, Utah, USA.
Matthew A MulveySchool of Biological Sciences, University of Utah, Salt Lake City, Utah, USA.
June L RoundDepartment of Pathology, Division of Microbiology and Immunology, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0002-7158-9874
Funding
TRAINING PROGRAM IN GENETICST32GM007464 · NIGMS · UNIVERSITY OF UTAH · PI GRUNWALD, DAVID J., STANFIELD, GILLIAN · 1985 to 2020
$6.1M
Microbiota-immune interactions that promote intestinal homeostasisR01AT011423 · NCCIH · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI ROUND, JUNE LOUISE · 2021 to 2025
$3.1M
University of Utah Genetics Training ProgramT32GM141848 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI GOLIC, KENT G, GRUNWALD, DAVID J. · 2021 to 2025
$2.9M
Bacteriophage pathobiology of inflammatory bowel diseaseR01DK124317 · NIDDK · UNIVERSITY OF UTAH · PI ROUND, JUNE LOUISE · 2020 to 2023
$2.5M
Impact of Flagellin Variants and Receptors on the Progression and Outcome of SepsisR01GM134331 · NIGMS · UNIVERSITY OF UTAH · PI MULVEY, MATTHEW A · 2019 to 2022
$1.6M
Determining how the human gut microbiota modulates colon cancer tumorigenesisF32CA243501 · NCI · UNIVERSITY OF UTAH · PI WEIS, ALLISON · 2019 to 2021
$200k
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1R01DK124317HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01AT011423NCCIH NIH HHS R01 AT011423NCI NIH HHS F32 CA243501NIDDK NIH HHS R01 DK124317NIGMS NIH HHS R01 GM134331NIGMS NIH HHS T32 GM007464NIGMS NIH HHS T32 GM141848W. M. Keck Foundation (WMKF)
6 · The paper itself
Abstract
We present the draft genome of a novel human-derived
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Draft genome of a human-derived · full record | OpenQuestion